BullFrog AI Announces Exclusive, Worldwide Licensing Agreement with Johns Hopkins’ Applied Physics Laboratory for Patented AI Technology
April 04 2023 - 8:00AM
BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("Bullfrog AI" or
the "Company"), a digital technology company using machine learning
to usher in a new era of precision medicine, is pleased to announce
its worldwide license agreement with Johns Hopkins University
Applied Physics Laboratory (“APL”) for use of patented technology
powering the Company’s bfLEAP™ platform.
BullFrog’s bfLEAP™ platform analyzes drug
development data to potentially make life-saving therapies and
treatments available to patients more quickly. The patented
technology from APL includes analytical models that enable the
analysis and interpretation of large, complex, and diverse datasets
that may be incomplete and comprise both numerical and categorical
data and provide explainable results. The innovative technology,
which enables the detection of anomalies, patterns, and
relationships, has been shown to perform better than well-known
algorithms in benchmarking tests.
“The ability to make predictions with incomplete
multimodal data and insufficient scalability of digital analytics
are two critical issues for researchers and clinicians today,” said
Vin Singh, Founder and CEO of BullFrog AI. “With the help of John
Hopkins APL’s patented technology, our bfLEAP™ platform is able to
overcome these challenges, enabling precise identification of
meaningful data for more agile drug development. We are excited to
apply this game-changing technology to both our internal drug
development and clinical testing initiatives, as well as in
strategic relationships with key partners in biopharma.”
BullFrog AI is deploying bfLEAP™ for use at
several critical stages of development with the intention of
streamlining data analytics in therapeutics development, decreasing
the overall development costs by decreasing failure rates for new
therapeutics, and impacting the lives of countless patients that
may otherwise not receive the therapies they need.
The licensed technologies from APL include
Prometheus and Seagull. Prometheus includes a comprehensive library
of APL-invented probabilistic models, one of which recently beat 10
competing algorithms in detecting anomalies in an extensive
benchmarking study done using 12 open-source data sets. Prometheus
also includes graph algorithms that have been successfully used to
analyze large-scale network resilience problems on multimodal
global networks, such as global logistics and communication
networks.
Seagull provides a comprehensive library of
multivariate time series analyses. Seagull can enrich time series
data by fusing it with open-source data as well as calculated
behavioral features. Besides “single-actor” analysis, Seagull also
provides efficient implementations of time series correlation and
clustering capabilities that allow it to rapidly discover
associations between entities in near linear time — a
computationally challenging task.
About BullFrog AI
BullFrog AI is a digital technology company
using machine learning to usher in a new era of precision medicine.
Through its collaborations with leading research institutions,
including Johns Hopkins University, BullFrog AI is at the forefront
of AI-driven drug development. Using its proprietary bfLEAP™
artificial intelligence platform, BullFrog AI aims to enable the
successful development of pharmaceuticals and biologics by
predicting which patients will respond to therapies in development.
BullFrog AI is deploying bfLEAP™ for use at several critical stages
of development with the intention of streamlining data analytics in
therapeutics development, decreasing the overall development costs
by decreasing failure rates for new therapeutics, and impacting the
lives of countless patients that may have otherwise not received
the therapies they need.
For more information visit BullFrog AI
at:Website: www.bullfrogai.comLinkedIn:
https://www.linkedin.com/company/bullfrogai/
About the Applied Physics
Laboratory
The Applied Physics Laboratory, a not-for-profit division of The
Johns Hopkins University, meets critical national challenges
through the innovative application of science and technology. For
more information, visit www.jhuapl.edu.
Forward-Looking Statements
This press release contains forward-looking statements. We base
these forward-looking statements on our expectations and
projections about future events, which we derive from the
information currently available to us. Such forward-looking
statements relate to future events or our future performance,
including: our financial performance and projections; our growth in
revenue and earnings; and our business prospects and opportunities.
You can identify forward-looking statements by those that are not
historical in nature, particularly those that use terminology such
as "may," "should," "expects," "anticipates," "contemplates,"
"estimates," "believes," "plans," "projected," "predicts,"
"potential," or "hopes" or the negative of these or similar terms.
In evaluating these forward-looking statements, you should consider
various factors, including: our ability to change the direction of
the Company; our ability to keep pace with new technology and
changing market needs; and the competitive environment of our
business. These and other factors may cause our actual results to
differ materially from any forward-looking statement.
Forward-looking statements are only predictions. The
forward-looking events discussed in this press release and other
statements made from time to time by us or our representatives, may
not occur, and actual events and results may differ materially and
are subject to risks, uncertainties, and assumptions about us. We
are not obligated to publicly update or revise any forward-looking
statement, whether as a result of uncertainties and assumptions,
the forward-looking events discussed in this press release and
other statements made from time to time by us or our
representatives might not occur.
Contact:Dave GentryRedChip Companies,
Inc.BFRG@redchip.com 800-733-2447
SOURCE: BullFrog AI Holdings, Inc.
Bullfrog AI (NASDAQ:BFRGW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bullfrog AI (NASDAQ:BFRGW)
Historical Stock Chart
From Jul 2023 to Jul 2024